Babu Yarlagadda S 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 16, 2021
Insider Transaction Report
Form 4
Babu Yarlagadda S
Chief Discovery Officer
Transactions
- Award
Common Stock
[F1]2021-12-14+35,000→ 250,056 total - Award
Emp. Stock Option (Right to Buy)
[F2]2021-12-14+164,000→ 164,000 totalExercise: $11.43From: 2022-12-14Exp: 2031-12-14→ Common Stock (164,000 underlying)
Footnotes (2)
- [F1]Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- [F2]Annual Employee Option Grant becomes exercisable at the rate of 25% of each of the first, second, third and fourth anniversaries of the date of grant.
Signature
/s/ Alane P. Barnes, by power of attorney|2021-12-16